Your browser doesn't support javascript.
loading
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab.
Ferraro, Emanuela; Singh, Jasmeet; Patil, Sujata; Razavi, Pedram; Modi, Shanu; Chandarlapaty, Sarat; Barrio, Andrea V; Malani, Rachna; Mellinghoff, Ingo K; Boire, Adrienne; Wen, Hannah Y; Brogi, Edi; Seidman, Andrew D; Norton, Larry; Robson, Mark E; Dang, Chau T.
Afiliação
  • Ferraro E; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Singh J; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Patil S; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
  • Razavi P; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine College, New York, NY, USA.
  • Modi S; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine College, New York, NY, USA.
  • Chandarlapaty S; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine College, New York, NY, USA.
  • Barrio AV; Breast Cancer Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Malani R; Brain Tumor Center, Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mellinghoff IK; Brain Tumor Center, Human Oncology and Pathogenesis Program, Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Boire A; Brain Tumor Center, Human Oncology and Pathogenesis Program, Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wen HY; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Brogi E; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Seidman AD; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine College, New York, NY, USA.
  • Norton L; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine College, New York, NY, USA.
  • Robson ME; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine College, New York, NY, USA.
  • Dang CT; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine College, New York, NY, USA. dangc@mskcc.org.
NPJ Breast Cancer ; 8(1): 37, 2022 Mar 22.
Article em En | MEDLINE | ID: mdl-35319017

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Risk_factors_studies Idioma: En Revista: NPJ Breast Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Risk_factors_studies Idioma: En Revista: NPJ Breast Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos